These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26853988)

  • 1. [Four cases of ceftriaxone-associated biliary pseudolithiasis].
    Niwa M; Tochii K
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(2):281-8. PubMed ID: 26853988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult].
    Jung HK; Lee DS
    Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.
    Yoshida R; Yoshizako T; Katsube T; Kitagaki H
    Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children.
    Meng D; Cao Y; Fu J; Chen R; Lu L; Tu Y
    J Int Med Res; 2010; 38(6):2004-10. PubMed ID: 21227004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On ceftriaxone and biliary pseudolithiasis].
    Ronchi B; Bona G
    Minerva Pediatr; 1997 Nov; 49(11):543-4. PubMed ID: 9549299
    [No Abstract]   [Full Text] [Related]  

  • 9. Endoscopic management of ceftriaxone pseudolithiasis involving the common bile duct and gallbladder.
    Lebovics E; Halata MS; Rosario JA; Lantin J; Schwarz SM; Rosenthal WS
    Gastrointest Endosc; 1994; 40(2 Pt 1):246-8. PubMed ID: 8013837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gallstones in association with the use of ceftriaxone in children].
    Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
    An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy.
    Blais C; Duperval R
    Pediatr Radiol; 1994; 24(3):218-9. PubMed ID: 7936805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary pseudolithiasis in childhood: a case report.
    Herek O; Sarioğlu A; Koçer N; Tiryaki A; Akkemik B
    Eur J Pediatr Surg; 1999 Oct; 9(5):337-9. PubMed ID: 10584197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of reversible biliary pseudolithiasis caused by ceftriaxone in childhood: does the problem deserve greater attention?].
    Parisi G; Rojo S; Mancinelli C; D'Alonzo L; De Fanis C
    Minerva Pediatr; 1997 Oct; 49(10):499-504. PubMed ID: 9557497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
    Li ZL; Li HL; Chen HW; Li HC; Zhang P; Wang ZM; Chong T
    Int Urol Nephrol; 2013 Feb; 45(1):73-6. PubMed ID: 23180444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.